Related Experiment Video
Updated: Jul 15, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study
C Pruunsild1, K Uibo, H Liivamägi
1Department of Paediatrics, Tartu University, Lunini 6 Tartu 51014, Estonia. Chris.Pruunsild@klinikum.ee
Insights
The incidence of juvenile idiopathic arthritis (JIA) in Estonia is 21.7 per 100,000 children, with a notable increase observed. Human leucocyte antigen (HLA)-B27 may indicate prolonged inflammation in JIA patients.
Area of Science:
- Rheumatology
- Pediatrics
- Epidemiology
Background:
- Juvenile idiopathic arthritis (JIA) is a significant rheumatologic condition in children.
- Understanding the epidemiology and clinical characteristics of JIA is crucial for effective management.
- Previous studies in Estonia using standardized criteria were limited.
Purpose of the Study:
- To determine the incidence and subtypes of JIA in Estonia.
- To track the disease course of newly diagnosed JIA patients over two years.
- To investigate the frequency of specific human leucocyte antigens (HLA) B27, DR1, and DR4 in JIA patients.
Main Methods:
- A prospective, population-based study was conducted.
- New JIA cases were registered between 1998 and 2000.
- Patients were clinically followed for two years, with HLA typing performed.
Main Results:
- 162 new JIA cases were identified, with a mean annual incidence of 21.7 per 100,000 children (aged 0-15).
- The incidence rate showed a 3.5-fold increase during the study period.
- Oligoarthritis was the most common subtype; HLA-B27 positivity was associated with prolonged inflammation markers.
Conclusions:
- This is the first Estonian population-based epidemiological study of JIA using International League of Associations for Rheumatology (ILAR) criteria.
- Increased family doctor awareness likely contributed to the rising incidence.
- HLA-B27 may serve as a predictive marker for chronic inflammation in JIA.
Objective:
To study the incidence rate of juvenile idiopathic arthritis (JIA) and its clinical subtypes in Estonia, to follow the course of the disease in newly diagnosed patients for 2 years, and to find the frequency of human leucocyte antigens (HLA) B27, DR1 and DR4 in JIA patients.
Method:
A population-based study involving prospective registration of new cases of JIA in 1998-2000 and their clinical follow-up for 2 years.
Results:
In 1998-2000, 162 new cases of JIA were diagnosed. The mean annual incidence rate of JIA was 21.7 per 100 000 children aged 0-15 years (22.9 in girls and 19.3 in boys). During the investigation period, the incidence rate rose 3.5-fold. Oligoarthritis was the most frequent subtype (mean annual incidence rate of 11.7 per 100 000), followed by seronegative polyarthritis (4.4 per 100 000). HLA-DR1, B27 and DR4 were found respectively in 44.4, 28.6 and 11.1% of cases in which the analysis was performed. In HLA-B27-positive patients, inflammation markers of blood remained at a high level for a longer period compared with HLA-B27-negative patients.
Conclusions:
This is the first population-based study on the epidemiology of juvenile arthritis in Estonia in which the new classification criteria defined by the International League of Associations for Rheumatology (ILAR) have been used. In addition to environmental factors, an increase in awareness among family doctors is a probable reason for the rise in incidence during the study period. HLA-B27 might have predictive value as a marker of chronicity of inflammation.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Bias in Epidemiological Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The JAK-STAT Signaling Pathway
Arboviral Encephalitis
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.